Sun Pharmaceutical Industries Limited (NSE: SUNPHARMA), ISIN INE044A01036 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SUNPHARMA last traded at ₹2008.40 (+0.94%), with a 52-week range of ₹1547.25 to ₹2009.70 (as of 30 Jul 2026).
Shareholding as of Jun 2026: promoters 54.48%, FIIs 14.53%, DIIs 22.18%, mutual funds 12.84%.
EquiSense Score (ECS): 81/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.